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Abstract
Background: Isoflavones are polyphenols with estrogenic activity found mainly in soy and soy-derived products
that need to be metabolised in the intestine by the gut bacteria to be fully active. There is little knowledge about
isoflavone bioconversion and equol production in the human intestine. In this work, we developed an in vitro
anaerobic culture model based on faecal slurries to assess the impact of isoflavone supplementation on the overall
intestinal bacterial composition changes and associated metabolic transformations.
Results: In the faecal anaerobic batch cultures of this study bioconversion of isoflavones into equol was possible,
suggesting the presence of viable equol-producing bacterial taxa within the faeces of menopausal women with an
equol producer phenotype. The application of high-throughput DNA sequencing of 16S rRNA gene amplicons
revealed the composition of the faecal cultures to be modified by the addition of isoflavones, with enrichment of
some bacterial gut members associated with the metabolism of phenolics and/or equol production, such as
Collinsella, Faecalibacterium and members of the Clostridium clusters IV and XIVa. In addition, the concentration of
short-chain fatty acids (SCFAs) detected in the isoflavone-containing faecal cultures was higher in those inoculated
with faecal slurries from equol-producing women.
Conclusions: This study constitutes the first step in the development of a faecal culturing system with isoflavones
that would further allow the selection and isolation of intestinal bacterial types able to metabolize these
compounds and produce equol in vitro. Although limited by the low number of faecal cultures analysed and the
inter-individual bacterial diversity, the in vitro results obtained in this work tend to indicate that soy isoflavones
might provide an alternative energy source for the increase of equol-producing taxa and enhancement of SCFAs
production. SCFAs and equol are both considered pivotal bacterial metabolites in the triggering of intestinal
health-related beneficial effects.
Keywords: Faecal slurry cultures, Faecal fermentation, Isoflavone metabolism, Equol, Intestinal microbiota,
High-throughput sequencing
* Correspondence: sdelgado@ipla.csic.es
1Department of Microbiology and Biochemistry, Instituto de Productos Lácteos
de Asturias (IPLA), Consejo Superior de Investigaciones Científicas (CSIC),
Asturias, Spain
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Guadamuro et al. BMC Microbiology  (2017) 17:93 
DOI 10.1186/s12866-017-1001-y
Background
Isoflavones are polyphenols with estrogenic activity
found at relatively high concentration in soy and soy-
derived products. Epidemiological studies suggest high
intakes of isoflavones to be associated with fewer and
less intense menopause symptoms, and a reduced inci-
dence of hormone-dependent and aging-associated dis-
eases such as osteoporosis, cardiovascular diseases and
cancer [1]. Although there is a growing body of scientific
evidence showing beneficial effects in counteracting
symptoms such as hot flushes and vasomotor reactions
in menopausal women [2], the European Food Safety
Authority (EFSA) has recently refuted health claims
about the role of isoflavones in body functions [3]. This
may be so because the functionality of isoflavones depends
on their bioavailability and their conversion into (more)
active metabolites within the intestinal tract. In nature,
isoflavones are mostly (>80%) conjugated with sugars as
isoflavone-glycosides (daidzin, genistin, glycitin) with low
availability and bioactivity [4]. For full activity, aglycones
(daidzein, genistein, glycitein) need to be released from
their glycosides and, occasionally, metabolized to more
potent metabolites, such as equol (produced from daid-
zein). Equol is the isoflavone-derived compound with the
strongest estrogenic activity and antioxidant capacity,
mechanisms by which isoflavones seem to provide the
purported beneficial health effects [5]. The conversion of
isoflavones into equol appears to be mainly carried out by
intestinal microorganisms, especially bacteria inhabiting
the distal portion of the gut [6]. Both, traditional and
molecular methods have revealed marked individual diver-
sity in intestinal bacterial communities. Such differences
in the bacterial community composition may, in fact, in-
fluence the fate of isoflavone metabolic transformations
[7, 8], which could ultimately contribute to differences in
the physiological response to isoflavone treatment.
In that sense, only 30–50% of Western individuals pro-
duce equol [5], and only these might fully benefit from
the positive health effects of isoflavone consumption.
The metabolism of isoflavones involves several steps me-
diated by enzymes provided by different bacterial taxa
[7, 8]. Even though scientific information is accumulat-
ing on the microorganisms producing equol, their en-
zymes and the metabolic routes involved, our current
knowledge is still limited [6, 9, 10]. Most of the equol-
producing bacteria characterized so far belong to the
family Coriobacteriaceae [7]. However, it is not yet clear
whether this family is the only intestinal group acting on
isoflavones and producing equol.
Previously, the metabolism of daidzein by faecal bacterial
consortia has been microbiologically characterized by con-
ventional culturing methods [11–13]. The availability of
high-throughput DNA sequencing techniques opens new
potentials to tracking changes in the bacterial communities
during isoflavone supplementation in both in vitro and in
vivo systems. A better knowledge about the identity and in-
dividual variability of the intestinal bacteria that metabolize
isoflavones and convert them into equol, would provide an
important step for developing strategies to increase bio-
availability and concentration of active compounds, e.g. by
supplying suitable equol-producing probiotic bacteria.
In this study, anaerobic batch cultures of faecal samples
from equol producer and non-producer menopausal
women (as determined by urine equol excretion of
>1000 nM) under treatment with soy isoflavones were
performed, using media with and without isoflavones, to
examine which bacteria take benefit from soy isoflavones
and could be involved in equol production. PCR- denatur-
ing gradient gel electrophoresis (DGGE) and high-
throughput DNA sequencing were used to determine
whether faecal cultures grown in the presence of isofla-
vones showed any change in their bacterial community
composition and/or structure. These molecular analyses,
based on PCR-amplified partial 16S rRNA gene sequences,
were complemented by metabolic profiling of the culture
supernatants using ultra-high-performance liquid chroma-
tography (UHPLC) and gas chromatography (GC). This
approach allowed the suggestion of links between struc-
tural responses in bacterial community compositions to
metabolic activities.
Methods
Stool samples from isoflavone-treated menopausal
women
Menopausal women who had been receiving treatment
for 6 months with 80 mg/day of an isoflavone concen-
trate (Fisiogen; Zambon, Bresso, Italy) were recruited.
Stool samples were obtained from four women whose
faecal microbiota had been characterized and whose
equol producer status during isoflavone treatment had
been determined in a previous study [14]. Three of the
women (WC, WG and WP) were equol producers (urine
equol >1000 nM as defined by Rowland et al. [15]), while
the fourth (WE) was a non-producer (<10 nM in urine).
Faeces were collected and transported to the laboratory
as previously described [14].
Faecal batch cultures
Ten-fold faecal dilutions were prepared by homogenizing
1 g of faeces in 9 ml of a pre-reduced phosphate buffer sa-
line solution (PBS) under strict anaerobic conditions (80%
N2, 10% CO2, 10% H2) in a Whitley DG500 Workstation
anaerobic chamber. A 10% (v/v) aliquot of the resulting
faecal slurry was used to inoculate the medium for colonic
bacteria (MCB) described by van der Meulen et al. [16],
modified to have a lower glucose content (2 g/l) (hereafter
referred to as mMCB). This medium was prepared without
and with a concentration of 160 mg/l commercial
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isoflavone supplement (Fisiogen) by dissolving two capsules
per liter of medium. One capsule of Fisiogen contains, as
stated in the package, 80 mg of isoflavone of which 55–72%
is genistin/genistein and 28–45% other soy isoflavones. It
also includes as excipients E341, E460, E468, E551, E472,
E464, E904, E171, and E124. The isoflavone-containing
medium is hereafter referred to as mMCBISO. These faecal
primary cultures thus prepared were incubated at 37 °C in
fermentation flasks with mild stirring (250 rpm) for 24 h
under anaerobic conditions. To find out whether produc-
tion of equol in vitro was maintained in successive subcul-
turings, primary cultures in mMCBISO were used as inocula
(10% v/v) for a second round of cultivation in fresh
mMCBISO. These new cultures were incubated as above
and referred to as secondary cultures.
Positive controls for isoflavone conversion and equol
production were obtained by inoculating (at 10%)
mMCBISO with the strains Slackia isoflavoniconvertens
DSM 22006 or Slackia equolifaciens DSM 24851. Both
these strains were grown under anoxic conditions in
Gifu Anaerobic Medium (GAM, Nissui Pharmaceutical,
Tokyo, Japan) supplemented with 0.5% arginine (Merck,
Darmstadt, Germany). After overnight culturing, cell of
the two strains were washed twice in pre-reduced PBS
before inoculating the media (mMCB and mMCBISO) or
the faecal cultures and incubated as above.
Detection and quantification of equol and its isoflavone
precursors
Equol and its isoflavone precursors [daidzin (daidzein-7-
O-glucoside) and daidzein] were measured using a
UHPLC procedure based on a method for equol deter-
mination in urine [17]. Briefly, after 24 h incubation, faecal
cultures were centrifuged at 800 rpm for 10 min, duplicate
samples of 3 ml of each supernatant collected, and their
isoflavone content extracted using Bond Elute-C18 solid-
phase cartridges (Agilent Technologies, Santa Clara, CA,
USA). After drying, organic extracts were dissolved in
100 μl of HPLC grade methanol, and 1 μl of each sample
injected into the UHPLC apparatus (Waters, Palo Alto,
CA, USA). Samples were analysed in duplicate. Equol was
quantified using a fluorescence detector (excitation
280 nm, emission 310 nm), while daidzin and daidzein
were identified with a photodiode array (PDA) detector by
comparison with their retention times and spectral char-
acteristics at 260 nm. Quantification was performed
against calibration curves prepared using commercial
standards (all from Sigma-Aldrich, St. Louis, MO, USA).
Short chain fatty acids determination
Short chain fatty acids (SCFAs) in the primary and sec-
ondary cultures were determined by GC. Culture superna-
tants were centrifuged for 10 min at 800 rpm, and then
for 10 min further at 13,200 rpm, before filtering through
0.45 μm PTFE filters. The filtered samples were then
mixed 10:1 (v/v) with 1 mg/ml of 2-ethyl butyric acid
(Sigma-Aldrich) dissolved in methanol as an internal
standard. A chromatographic system composed of 6890 N
GC apparatus (Agilent Technologies) connected to a
flame ionization detector was used to identify and quantify
the SCFAs as described elsewhere [18]. All samples were
analysed in triplicate. The Shapiro–Wilk test was initially
used to check for the normal distribution of the data.
Since the data were not normally distributed, we used the
non-parametric Wilcoxon signed-rank test to examine the
differences in the content of SCFAs between the faecal
cultures with (mMCBISO) and without isoflavones
(mMCB). This statistic test is used to assess differences
between related groups of samples and in our case the
same faecal cultures were analysed under two different
conditions (mMCB versus mMCBISO). All these calcula-
tions were performed using the SPSS software v.22.0.
Microbial community analysis
DNA extraction
Total bacterial DNA was extracted from the faecal primary
and secondary cultures using the phenol-chloroform-based
protocol of Zoetendal et al. [19] with modifications as
described elsewhere [20]. The main modification consisted
in the addition of an enzymatic lysis step before mechanical
disruption in a FastPrep FP120 apparatus (Qbiogene,
Carlsbad, CA, USA). After precipitation and drying, DNA
samples were suspended in 100 μl of sterile molecular biol-
ogy grade water (Sigma-Aldrich).
PCR-denaturing gradient gel electrophoresis (DGGE)
analysis
Total DNA from the faecal cultures with and without
isoflavones was used as a template for amplification of
the variable region V3 of the 16S rRNA gene by PCR
using the universal prokaryotic primers F357-GC and
R518 [21]. DGGE electrophoresis was performed as de-
scribed elsewhere [14]. DNA from S. equolifaciens and S.
isoflavoniconvertens was used to provide DGGE markers.
Genomic DNA from these strains was obtained from
overnight cultures in GAM + 0.5% arginine using the
GenElute Bacterial Genomic DNA kit (Sigma-Aldrich)
and subsequently employed in PCR amplifications.
Amplicons were purified using GenElute PCR Clean-Up
columns (Sigma-Aldrich) and mixed in equal amounts
to obtain a DGGE marker.
High-throughput DNA sequencing and analysis of 16S rRNA
gene amplicons
DNA samples obtained from the primary and secondary
cultures were subjected to PCR amplification of the variable
region V4-V5 of the 16S rRNA gene using the universal
prokaryotic primers 515F and 909R [22]; these were
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designed to include Illumina adapters. Double indexed
amplicons were generated by the protocol of Caporaso et
al. [23] with minor modifications. In brief, DNA from the
samples was extracted in duplicate and amplified in tripli-
cate; in total, 72 amplification reactions were obtained.
These were subsequently paired-end sequenced in an
Illumina Miseq System (Illumina, San Diego, CA, USA) by
the StarSeq Company (Mainz, Germany), and treated as
independent replicates.
Bioinformatic analysis was performed using the Mothur
software package (v.1.34.1) following the MiSeq Standard
Operating Procedure (SOP) [24]. Briefly, sequences longer
than 380 bp in length, or shorter than 370 bp, and those
containing ambiguous base pairs or homopolymers re-
gions of >8 bp were removed. All other sequences were
aligned using the SINA alignment service of the SILVA
16S rRNA sequence database. Chimera removal was per-
formed using the UCHIME algorithm [25]. A random
subset of 35,000 sequences per sample was used to bal-
ance numbers of reads among samples. Sequences were
then clustered into operational taxonomic units (OTUs)
using a 0.03 dissimilarity cut-off. Sequences were taxo-
nomically classified using the Ribosomal Database Project
(RDP) database. The Bayesian classifier with an 80% confi-
dence threshold was used in the taxonomic assignment
with the genus level as the lowest taxonomic unit consid-
ered. The MOTHUR program was also used to perform
weighted UniFrac analysis, which was employed to assess
the similarity of the microbial communities between sam-
ples. Construction of a heatmap was performed using the
R statistical software. Clustering was accomplished using
the complete linkage method with Euclidean distance
measure. Multivariable statistical analysis was performed
by principal coordinates analysis (PCoA) and non-metric
multidimensional scaling (NMDS) with two dimensions.
Differences in the microbial composition of faecal cultures
with and without isoflavones were sought by analysis of
molecular variance (AMOVA) and analysis of similarities
(ANOSIM). The identification of differentially abundant
taxa was assessed using the Metastats software [26]. Mul-
tiple hypothesis tests were adjusted using the false discov-
ery rate (FDR) correction [27]; an FDR q-value threshold
of 0.25 was used to identify significant differences. In an
attempt to assign the differential OTUs at the species
level, manual sequence comparisons were performed
against the Greengenes 16S rRNA gene database.
Results
Isoflavone conversion and equol production
The uninoculated medium with isoflavones, mMCBISO,
was shown by UHPLC to contain three times more conju-
gated precursor daidzin that its corresponding aglycone
daidzein (Table 1). As expected, equol was never detected
in the absence of isoflavones in the cultures. In the
medium inoculated with S. equolifaciens DSM 24851, used
as a positive control for equol production, daidzin levels
were maintained while daidzein was transformed and con-
verted to equol, reaching 2 μg/ml after 24 h incubation. In
the primary faecal cultures from the three equol producers
(WC, WG and WP) comparable amounts of equol to that
produced by the positive control were recorded (1.40–
3.07 μg/ml). Congruently, daidzin levels were drastically
reduced in these cultures, indicating glycosidase activity
from faecal bacteria towards this isoflavone glycoside. In
the primary culture from the non-producing woman
(WE), daidzin was also shown to decrease while daidzein
accumulated, but no equol was found (limit of quantifica-
tion 0.002 μg/ml). As expected, in the secondary culture
from this woman equol was not detected either. In
contrast, equol production was maintained to some extent
in the secondary cultures from two of the three equol
producers (WG and WP).
SCFA production
Comparing the results obtained in the mMCB medium,
total SCFA production was greater in the faecal cultures
containing isoflavones (mMCBISO) (Fig. 1). The concen-
trations of the major SCFAs (acetic, propionic and butyric
acids) were particularly enhanced in the primary faecal
cultures whose inocula came from the equol-producing
women (Table 2); significant increases were seen for pro-
pionic acid and isobutyric and isovaleric acids (the latter
two are minority, branched chain fatty acids [BCFAs])
(p < 0.05). In contrast, in the cultures from the equol non-
producing woman (WE), no differences between the cor-
responding mMCBISO and mMCB were seen for major or
minor SCFAs in the primary cultures. Consequently, the
acetic/propionic ratio for this faecal culture was five times
higher than that recorded for the equol producers; indeed,
the concentration of propionic and butyric acids for this
culture were much lower than those recorded in the pri-
mary cultures of the equol-producing women. SCFAs pro-
duction in the secondary cultures from these women was
maintained to some extent, but with a major reduction in
the concentration of isovaleric acid.
Bacterial community analysis by PCR-DGGE
The structural diversity of the bacterial communities
in the primary faecal cultures was initially investigated
by PCR-DGGE. In samples from the mMCBISO
medium inoculated with S. equolifaciens or S. isoflavo-
niconvertens, faint bands corresponding to the ex-
pected size for these species were appreciated
(Additional file 1). Clear differences were seen in the
bacterial DGGE patterns of the cultures for the differ-
ent women. However, no changes were observed in
the profiles for the mMCB and mMCBISO faecal cul-
tures from the same woman. This suggested to us
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that the presence of isoflavones did not affect under
the experimental culture conditions employed the
dominant bacterial populations. Therefore, the bacter-
ial communities of the secondary cultures were not
further analysed using this technique.
Bacterial community analysis by high-throughput DNA
sequencing
The application of the Illumina technology allowed
obtaining an average of 111,542 high quality PCR-
amplicon sequences for each replicate. The number of
high quality sequences among all the replicates ranged
between 71,138–150,292, and estimated sample coverage
was considered to be good for all libraries. The mean
number of quality sequences retrieved per faecal culture,
together with the numbers of OTUs, as defined by ≥97%
sequence identity, and α-diversity indexes calculated for
each sample are summarized in Additional file 2. To
allow further comparative analyses between samples,
each 16S rRNA gene amplicon library was rarefied to
35,000 sequences per replicate. The rarefaction curves
for the normalized sequences showed that the secondary
culture for subject WC (which did not render equol in
vitro) was the least diverse (Fig. 2). Further, the numbers
of OTUs obtained in all cultures (primary culture in
mMCB, primary culture in mMCBISO, and secondary
culture in mMCBISO) from the equol non-producer sub-
ject WE were smaller (2000–2300 OTUs) than for all
other cultures (3000–3500 OTUs) (Additional file 2).
Compared to the faecal cultures in mMCB, the presence
of isoflavones had no significant influence on the rich-
ness index Sobs (number of observed species) (Fig. 3).
However, a significant reduction of the bacterial diversity
was recorded for the secondary cultures (p < 0.01).
Sequences were then taxonomically assigned using the
RDP classifier. A majority of sequences in all samples
belonged to the phylum Firmicutes (mean 55%), while se-
quences from Bacteroidetes (27%), Actinobacteria (9%) and
Proteobacteria (7%) phyla were less abundant. At this taxo-
nomic range, only 0.1% of the sequences remained unclassi-
fied/unassigned. At the genus-level, between 52 and 75
different genera were identified within each faecal culture.
Table 1 Isoflavone levels (μg/ml) in faecal cultures from equol-
producing and non-producing women in mMCBISO medium
Sample Isoflavone Primary
cultures
Secondary
cultures
WCa Daidzin 0.24 ± 0.09 24.69 ± 5.10
Daidzein 1.74 ± 0.07 under LOQc
Equol 2.62 ± 0.04 under LOQ
WGa Daidzin 0.05 ± 0.02 0.12 ± 0.06
Daidzein under LOQ under LOQ
Equol 3.07 ± 0.24 7.67 ± 0.64
WPa Daidzin 0.09 ± 0.04 0.18 ± 0.07
Daidzein 0.02 ± 0.01 under LOQ
Equol 1.40 ± 0.06 4.02 ± 0.35
WEb Daidzin under LOQ under LOQ
Daidzein 24.10 ± 3.32 45.57 ± 5.46
Equol under LOQ under LOQ
Uninoculated culture media Daidzin 16.83 ± 2.89 N.A.
Daidzein 5.57 ± 1.19 N.A.
Equol under LOQ N.A.
Slackia equolifaciens Daidzin 16.53 ± 3.68 N.A.
Daidzein 0.06 ± 0.05 N.A.
Equol 2.01 ± 0.10 N.A.
N.A. not applicable, mMCBISO modified medium for colonic bacteria
supplemented with isoflavones
aequol-producing woman
bequol non-producing woman
cLOQ Limit of quantification (0.002 μg/ml for equol; 0.004 μg/ml for daidzein
and 0.014 for daidzin)
Fig. 1 Production of short chain fatty acids (SCFAs). Comparison of total SCFAs production by the primary faecal cultures in media without
(mMCB) and with (mMCBISO) isoflavones
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Among the dominant genera Bacteroides presented the
highest percentage with a relative abundance between 10
and 20% of assigned reads; Faecalibacterium ranged
between 5 and 10%; and sequences related to the Clostrid-
ium “sensu stricto” group also reached these percentages
(5–10%), but only in the primary cultures from the equol
non-producing woman (Fig. 4). Sequences assigned to the
genus Collinsella also ranged within these abundances in
the primary cultures from the equol producers.
Subdominant genera, varying in percentage from 1 to 5%,
were represented by Parabacteroides, Ruminococcus and
Dorea; the latter only in the primary cultures from equol pro-
ducers. In agreement with the DGGE results, the bacterial
composition profile obtained by 16S rDNA sequencing was
quite similar for equivalent faecal cultures when grown with
and without isoflavones (Fig. 4). Nonetheless, changes in sub-
dominant, minor and assumingly rare genera were revealed
by the high throughput DNA sequencing technique.
A heatmap depicting relative abundances across sam-
ples (including primary and secondary cultures) is shown
in Fig. 5. In general, primary faecal cultures in mMCB
and mMCBISO from the same woman clustered together
suggesting similar microbial profiles, as denoted previ-
ously by DGGE. On the other hand, the secondary cul-
tures, with major changes in the bacterial communities’
patterns, plotted in a separate branche.
Fig. 2 Rarefaction curves calculated for each sample of the study. Rarefaction curves at a 97% similarity level of partial sequences of the bacterial
16S rRNA gene from primary and secondary faecal cultures in media with (mMCBISO) and without (mMCB) isoflavones
a b
Primary cultures in mMCBISO Primary cultures in mMCB Primary cultures Secondary cultures
Fig. 3 Differences in richness indices between faecal cultures. Comparison of Sobs, number of observed species, for the 16S rRNA gene
sequences at 3% of divergence distance of: a) primary faecal cultures in media with (mMCBISO) and without (mMCB) isoflavones, and b) primary
and secondary cultures in media with isoflavones. Asterisks denoted statistically significant differences (Welch’s test, p value < 0.01)
Guadamuro et al. BMC Microbiology  (2017) 17:93 Page 7 of 13
The application of the Metastats method (FDR correc-
tion 0.25) revealed that the presence of isoflavones in the
culture medium altered the abundance at several taxo-
nomic hierarchies. For example, the phylum Bacteroidetes
was less represented in the presence of isoflavones
(p = 0.001), in particular the family Bacteroidaceae with a
decrease of reads from the genera Bacteroides and Para-
bacteroides (Additional file 3). On the contrary, the repre-
sentation of the family Ruminococcaceae significantly
increased with isoflavones (p = 0.011). At the genus level,
increases were recorded for Roseburia and Odoribacter se-
quences. Reads of these two genera were still significantly
more abundant when excluding from analysis the faecal
culture from the equol non-producing woman (WE). If
omitting samples from this woman, and by comparing fae-
cal primary cultures with secondary cultures in the pres-
ence of isoflavones, two genera belonging to the family
Coriobacteriaceae (capable of synthesizing equol) were
significantly increased, Slackia (p = 0.019) and Eggerthella
(p = 0.030). Comparison of the microbial communities in
the mMCBISO primary cultures for equol producers with
that of the non-producer revealed a significant increase in
the number of sequences belonging to 28 different genera
(Additional file 4). The same number of genera showed an
increased in relative abundance when comparing second-
ary cultures producing equol with those that did not
(Additional file 5). Fifteen of the 28 genera (Collinsella,
Faecalibacterium, Dorea, Suterella, Clostridium (groups
XIVa and XIVb), Alistipes, Oscillibacter, Barnesiella,
Coprococcus, Finegoldia, Butyricicoccus, Asaccharobacter,
Murdochiella, Allisonella and Odoribacter) were found in
both the primary and their derived secondary cultures,
suggesting these groups to be more abundant in cultures
yielding equol. Of note was the appearance of Collinsella
(a member of the family Coriobacteriaceae not described
as equol producer), which accounted for 6–15% of se-
quences in cultures that produced equol, while reads for
this genus in isoflavone-containing cultures that did not
yield equol was less than 0.04%. Furthermore, reads of the
genus Asaccharobacter, a member of the same family har-
bouring equol-producing strains, increased significantly in
all cultures producing equol.
To visualize the overall differences between the bacter-
ial community structures, multivariate statistical ana-
lyses, i.e., NMDS and PCoA were applied. This revealed
that the bacterial communities of the women’s faecal pri-
mary and secondary cultures clustered together, with the
exception of that of the secondary culture for woman
WC (which, as stated above, showed a reduced diversity
and did not produce equol) (Fig. 6). The cluster for the
microbiota of this latter sample and those for the pri-
mary/secondary cultures for the equol non-producing
subject (WE), lay at an appreciable distance from the
cultures derived from equol producers (stress value
0.206 in NMDS). Further, the bacterial communities of
the mMCBISO cultures for the equol- producing women
showed more similarity to one another than to those
grown in mMCB. AMOVA revealed the clustering of the
Fig. 4 Bacterial composition at the genus level of primary faecal cultures. WC, WG and WP are equol producers meanwhile WE is an equol non-producer.
Composition is represented as the mean relative abundance of the six replicates sequenced. Only genera contributing with a percentage > 0.05% of the
total abundance in a least one sample are shown
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two types of samples (in mMCBISO and mMCB) to be
significantly different (p = 0.036).
Finally, OTUs significantly different in abundance
between primary faecal cultures grown in in mMCBISO and
in mMCB were manually assigned to the species level
(sequence identity higher that 97%). In cultures grown with
isoflavones, OTUs belonging to Faecalibacterium prausnit-
zii, Eubacterium halli, Subdoligranulum variabile, Rumino-
coccus flavefaciens/callidus, Blautia obeum and Bacteroides
xylanisolvens/ovatus were increased (Additional file 6).
Discussion
In this work, the bacterial diversity and metabolic changes
in cultures of faecal samples from isoflavone-treated
menopausal women were investigated. For that purpose,
an in vitro anaerobic batch culture system in a modified
medium for colonic bacteria supplemented or not with
isoflavones was developed. Production of equol was deter-
mined with a recently described UHPLC method [17] and
verified by inoculating the isoflavone-containing medium
with S. equolifaciens, an equol-producing bacterium. Simi-
lar levels of equol production to those obtained with this
control strain were recorded in the primary faecal cultures
for women with an equol producer phenotype (as deter-
mined previously by equol urinary excretion [14]) - but
not in the faecal cultures from a non-equol producer. This
strongly indicates differences among the faecal samples in
types and/or numbers of intestinal bacteria with capacity
to produce equol. The stability of isoflavone bioconversion
into equol was further tested by making subcultures of the
Fig. 5 Heatmap based on mean relative abundances of major genera across primary and secondary faecal cultures. Legend: WC, WG and WP are
equol producers meanwhile WE is an equol non-producer. Faecal cultures were grown in media with (mMCBISO) and without (mMCB) isoflavones.
Only genera contributing to >0.1% of the total abundance in at least one sample are represented in the vertical axis. Colour key: each colour
represent a value range of relative abundance that was selected for optimal visualization ranging between 0 and 55%. Hierarchical clustering of
samples was performed with the complete linkage and Euclidean distance through R package
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faecal primary cultures in fresh media. In the presence of
isoflavones, equol production was maintained in all except
one of these secondary cultures, suggesting that, under
the experimental conditions, bacterial types capable of
metabolizing isoflavones and producing equol maintain
viability and the equol-producing capability, which opens
possibilities for a rational propagation and selection of
these bacteria. It should be noted that with the UHPLC
methodology used in this study other daidzein-derived
metabolites that could be formed in the faecal cultures,
such as hydroxydadidzein (DHD) and O-desmethylango-
lensin (O-DMA), might have passed undetected.
In our study, the bacterial composition of the faecal
primary and secondary cultures was characterized by
two culture-independent methods. PCR-DGGE analysis
revealed no major changes in the bacterial communities
between the primary cultures with and without isofla-
vones. This would suggest that the dominant gut popu-
lations are a priori neither involved in the metabolism of
isoflavones nor influenced by the presence of these com-
pounds. However, the 16S rDNA sequencing data re-
vealed significant changes in different taxa in the
presence of isoflavones, particularly with respect to mi-
nority groups, which cannot be tracked by the DGGE
technique. Although the diversity observed in the faecal
cultures was similar in the media with and without
isoflavones, a larger number of OTUs was scored in
samples yielding equol. This suggests a more diverse
bacterial community coming from the faeces of women
with an equol producer status.
Collinsella was one of the genera that increased in
abundance considerably, both in the primary and secondary
cultures that produced equol. This genus belongs to
Coriobacteriaceae, a family that harbours most of the cur-
rently described equol-producing bacteria [7]. Increases in
the number of Collinsella sequences in response to isofla-
vone treatment have recently been reported in vivo [28].
Although to a lesser extent, the number of reads associated
with the genus Asaccharobacter also increased significantly
in the faecal cultures producing equol. This agrees with the
fact that the single species of this genus, Asaccharobacter
celatus, has been reported to be an equol producer [29].
Other intestinal bacteria recently associated with isoflavone
metabolism in humans, such as Dorea and Finegoldia [28,
30], were also significantly increased in all cultures produ-
cing equol. In agreement with the present results, isofla-
vones have further been described to stimulate in vivo
majority microorganisms of the Clostridium clusters XIVa
and IV, to the latter of which F. prausnitzii belongs [31, 14].
On the other hand, like other polyphenols, isoflavones may
a b
Fig. 6 Clustering of operational taxonomic units (OTUs) of primary and secondary cultures. Legend: Non-metric multidimensional scaling (NMDS)
(a), and principal coordinates analysis (PCoA) (b) showing clustering of the OTUs of the faecal cultures in this study. The blue circle embraces
samples from the equol non-producing woman; the yellow circle includes primary cultures in medium with isoflavones from the equol-producing
women; the dotted line separates samples that did not render equol
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have antimicrobial activity, which could modulate the
diversity and composition of the faecal bacterial communi-
ties [10]. In this work, addition of isoflavones to the faecal
cultures drove to a decrease of some taxa. In particular, the
genera Bacteroides and Parabacteroides reduced their num-
bers in the presence of these compounds.
Papers reporting production of equol in slurry cultures
inoculated with faeces from equol producing subjects
have been published previously [12, 13, 30]. However, as
far as we are aware, this is the first study that making
use of a soy isoflavone extract (commercial formulation)
added directly to a colonic culturing medium, describes
in deep the bacterial changes and response to isoflavone
enrichment by high-throughput 16S DNA sequencing.
Although this, the presence in the supplement of other
minor components apart from isoflavones (excipients)
that might influence the faecal bacterial communities
cannot be completely ruled out.
Production of SCFAs (relevant gut bacterial metabolites)
was determined in the batch faecal cultures in relation
with the addition of isoflavones and the production of
equol. SCFAs production in the colon results from bacter-
ial fermentation of dietary starches, fibre and sugars [32].
The SCFAs acetic (C2), propionic (C3) and butyric (C4)
acids are the main fermentation end-products in the gut,
and are thought to have anti-inflammatory and anti-
carcinogenic activities [33]. In contrast, BCFAs, such as
isobutyric and isovaleric acids, often associated with pro-
tein breakdown, have been less studied. The present data
reveal changes in SCFA production in the presence of iso-
flavones. The increased quantities of the main SCFAs
(acetic, propionic and butyric) and BCFAs in the faecal
cultures with isoflavones indicates microbial activity lead-
ing to the production of these compounds. The soy
isoflavone-glycosides can be initially deconjugated by en-
dogenous intestinal bacteria with hydrolytic activity (prob-
ably β-glucosidases), as it was observed in this study with
the reduction in the daidzin levels after cultivation. This
activity releases isoflavone aglycones [34], but also sugars
that may provide an alternative energy source to the
cultures. This would agree with some studies involving
prebiotic-related compounds such as beta-glucan or
cellobiose, which have been shown to increase BCFAs
production [35, 36]. At the genus level, Roseburia and
Odoribacter sequences were both significantly increased
in mMCBISO as compared to the medium without isofla-
vones. Reduction in members of these two genera has
been suggested to enhance inflammation by decreasing
SCFA availability [37, 38]. Although not statistically sig-
nificant, butyrate production in this work was greater in
the faecal cultures that produced equol. Butyrate-
producing bacteria such as Roseburia, E. hallii (both from
Clostridium cluster XIVa) and F. prausnitzii were more
abundant when faecal cultures were incubated with
isoflavones, particularly in those that produce equol.
When significant OTUs were assigned manually at the
species level other cellulolytic butyrate producers, such as
R. flavefaciens and S. variabile (both of the Clostridium
cluster IV) [37], and propionate producers from the
Clostridium cluster XIVa, such as B. obeum, were also
identified.
Cross-feeding mechanisms among the more diverse
faecal microbiota in equol producers might further be
partly responsible for the increased production of
propionic and butyric acids in isoflavone-containing
cultures. Acetate is the predominant SCFA produced by
bacterial fermentation in the gut, and both, F. prausnitzii
and E. hallii (the sequences of which became more
abundant when cultures were grown in the presence of
isoflavones) are well known acetate-utilizing, butyrate-
producing species [33].
Finally, isoflavone metabolism might also be affected
by the presence of SCFAs; i.e., butyric acid has been
shown to enhance equol production by A. celatus [29],
and an increase production of equol by a mixed micro-
bial culture from human faeces in the presence of propi-
onate and butyrate has also been reported [30].
Conclusions
Faecal cultures from women with an equol producer pheno-
type yielded equol in vitro in faecal fermentations with iso-
flavones, suggesting the presence in faeces of active bacterial
types able to produce this compound. The application of
high-throughput DNA sequencing of 16S rRNA gene PCR
amplicons revealed the composition of the faecal bacterial
communities to be modified by the presence of isoflavones,
including increases in equol-producing taxa. Although lim-
ited by the low number of cultures, isoflavones seem also to
promote, at least in vitro, SCFAs production. This increase
might be due to the growth stimulation of specific SCFA-
producing bacterial types from the Ruminococaceae (mem-
bers of the Clostridium cluster IV) and Lachnospiraceae
(Clostridium cluster XIVa) families.
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